GRAL·Nasdaq·US
GRAIL
GRAIL is a healthcare diagnostics company focused on multi-cancer early detection. It commercializes the Galleri blood test and also earns smaller revenue from development services.
Recent Activity
Updated Oct 3, 2026
–A panel of independent experts advising the FDA found that the probable benefits of GRAIL's Galleri multicancer detection blood test outweigh its risks.
–The FDA advisory panel noted that the Galleri test should not be used to replace medical guideline-recommended cancer screenings.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.